Ambea AB (publ) (LON:0RNX)
119.20
-0.69 (-0.57%)
At close: Jul 18, 2025
Ambea AB Revenue
Ambea AB had revenue of 3.64B SEK in the quarter ending March 31, 2025, with 4.59% growth. This brings the company's revenue in the last twelve months to 14.48B, up 4.79% year-over-year. In the year 2024, Ambea AB had annual revenue of 14.32B with 5.53% growth.
Revenue (ttm)
14.48B SEK
Revenue Growth
+4.79%
P/S Ratio
0.67
Revenue / Employee
382.42K SEK
Employees
37,864
Market Cap
746.12M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 14.32B | 751.00M | 5.53% |
Dec 31, 2023 | 13.57B | 934.00M | 7.39% |
Dec 31, 2022 | 12.64B | 1.16B | 10.08% |
Dec 31, 2021 | 11.48B | 395.00M | 3.56% |
Dec 31, 2020 | 11.08B | 43.00M | 0.39% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |